Stifel analyst Daniel Arias reiterated a Buy rating and $207.00 price target on Repligen (NASDAQ: RGEN)The analyst comments "Reuters is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE